Abstract
This thesis focuses on identifying prognostic and predictive biomarkers that may guide treatment decisions for patients with early-stage HER2-negative breast cancer (BC) or triple-negative BC (eTNBC). We studied the value of histopathologic tumor traits, in addition to stromal-compartment tumor infiltrating lymphocyte (sTIL) levels, in the risk stratification of young patients
... read more